Higher sleep variability is associated with poorer memory trajectories over time in middle-aged and older adults
In the ALBION study of 184 adults (mean age 65, 65% women), time-varying analyses showed that sleep variability had robust non-linear associations with poorer memory trajectories over a 1.5-year follow-up, remaining significant after FDR correction. Cross-sectionally, more nightly awakenings were associated with poor memory and attention speed. The findings suggest that objective indicators of sleep continuity, particularly sleep variability, are most consistently related to domain-specific cognitive outcomes, with strongest evidence for memory decline over time.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Higher sleep variability is associated with poorer memory trajectories over time in middle-aged and older adults The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 34/100 (low).
The Claim
Higher sleep variability is associated with poorer memory trajectories over time in middle-aged and older adults
This conclusion is most relevant to: Middle-aged and older adults (age > 40) from the ALBION study, including cognitively healthy individuals and those with mild cognitive impairment (N=184 at baseline, n=93 at follow-up).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Objective Sleep Measures and Cognition in Middle-Aged and Older Adults: A Cross-Sectional and Longitudinal Analysis in the ALBION Study. (Medical sciences (Basel, Switzerland), 2026) —
How It Works
The proposed biological pathway:
- ▸Sleep variability disrupts circadian rhythms and neural consolidation processes
- ▸Irregular sleep patterns impair hippocampal-dependent memory consolidation during sleep
- ▸Fragmented sleep reduces slow-wave sleep and synaptic homeostasis
- ▸Result: Accelerated decline in memory performance over time
Who Might Benefit
Evidence fit by population:
- ▸Middle-aged and older adults (age > 40) from the ALBION study, including cognitively healthy individuals and those with mild cognitive impairment (N=184 at baseline, n=93 at follow-up)
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Small sample size at follow-up (n=93) may limit generalizability and statistical power
- ▸Observational design cannot establish causality between sleep variability and cognitive decline
- ▸Short follow-up duration (1.5 years) may not capture long-term cognitive trajectories
Frequently Asked Questions
What is sleep variability and why is it important for cognition?▼
Sleep variability refers to day-to-day fluctuations in sleep duration and timing. The study found it was the most robust predictor of memory decline, suggesting that irregular sleep patterns may be more harmful than average sleep duration alone.
How was sleep measured in this study?▼
Sleep was measured objectively using wrist actigraphy (Actiwatch 2) over 7 days, capturing metrics like sleep duration, efficiency, variability, onset latency, wake after sleep onset, and number of awakenings.
Did the study find any cognitive benefits of better sleep?▼
Yes, higher baseline sleep efficiency was associated with better memory and language performance over follow-up, while longer wake after sleep onset, more awakenings, and longer sleep onset latency were linked to less favorable cognitive trajectories.
Who participated in the ALBION study?▼
Participants were middle-aged and older adults (mean age 65, 65% women) from Greece, including both cognitively healthy individuals and those with mild cognitive impairment.
References
- 1.Tsapanou A, Margoni A, Pavlou E, Ntanasi E, Mamalaki E, Manolakos E, Yannakoulia M, Scarmeas N, Papandreou C. “Objective Sleep Measures and Cognition in Middle-Aged and Older Adults: A Cross-Sectional and Longitudinal Analysis in the ALBION Study..” Medical sciences (Basel, Switzerland), 2026. PMID: 42506309 DOI: 10.3390/medsci14030340